INMB > 4M trading float > INmune Bio shares are trading higher after the company announced clinical data that demonstrated XPro1595, its lead drug candidate, decreased neuroinflammation in patients with Alzheimer's disease.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.